Recent Finacing
Recent Raise
CeloNova BioSciences develops and markets cardiovascular medical devices that leverage its proprietary Polyzene-F nanocoating technology, most notably the FDA-approved COBRA PzF NanoCoated Coronary Stent.
Focus Areas
Recent Investors
Funding round
Investors
See the team members at CeloNova.
